Raymond James Financial Services Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-18,318
| Closed | -$3.97M | – | 3342 |
|
|
2021
Q1 | $3.97M | Sell |
18,318
-15,835
| -46% | -$3.43M | 0.01% | 1006 |
|
|
2020
Q4 | $3.94M | Buy |
34,153
+6,701
| +24% | +$773K | 0.01% | 939 |
|
|
2020
Q3 | $2.67M | Buy |
27,452
+10,991
| +67% | +$1.07M | 0.01% | 1031 |
|
|
2020
Q2 | $2.02M | Sell |
16,461
-508
| -3% | -$62.3K | 0.01% | 1117 |
|
|
2020
Q1 | $1.49M | Buy |
16,969
+546
| +3% | +$47.8K | 0.01% | 1031 |
|
|
2019
Q4 | $1.72M | Sell |
16,423
-853
| -5% | -$89.2K | 0.01% | 1238 |
|
|
2019
Q3 | $1.99M | Sell |
17,276
-1,674
| -9% | -$193K | 0.01% | 1114 |
|
|
2019
Q2 | $3.27M | Buy |
18,950
+1,686
| +10% | +$291K | 0.01% | 852 |
|
|
2019
Q1 | $2.91M | Buy |
17,264
+734
| +4% | +$124K | 0.01% | 886 |
|
|
2018
Q4 | $1.61M | Sell |
16,530
-1,184
| -7% | -$115K | 0.01% | 1015 |
|
|
2018
Q3 | $3.06M | Buy |
17,714
+8,437
| +91% | +$1.46M | 0.01% | 851 |
|
|
2018
Q2 | $1.3M | Buy |
9,277
+3,990
| +75% | +$557K | 0.01% | 1267 |
|
|
2018
Q1 | $596K | Buy |
5,287
+916
| +21% | +$103K | ﹤0.01% | 1617 |
|
|
2017
Q4 | $577K | Buy |
4,371
+671
| +18% | +$88.6K | ﹤0.01% | 1630 |
|
|
2017
Q3 | $376K | Buy |
3,700
+581
| +19% | +$59K | ﹤0.01% | 1893 |
|
|
2017
Q2 | $313K | Buy |
3,119
+855
| +38% | +$85.8K | ﹤0.01% | 1963 |
|
|
2017
Q1 | $274K | Buy |
+2,264
| New | +$274K | ﹤0.01% | 1953 |
|
|
2016
Q4 | – | Sell |
-18,525
| Closed | -$2.46M | – | 2414 |
|
|
2016
Q3 | $2.46M | Buy |
+18,525
| New | +$2.46M | 0.02% | 671 |
|